Cargando…

Establishment, functional and genetic characterization of three novel patient-derived rectal cancer cell lines

AIM: To establish patient-individual tumor models of rectal cancer for analyses of novel biomarkers, individual response prediction and individual therapy regimens. METHODS: Establishment of cell lines was conducted by direct in vitro culturing and in vivo xenografting with subsequent in vitro cultu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gock, Michael, Mullins, Christina S, Bergner, Carina, Prall, Friedrich, Ramer, Robert, Göder, Anja, Krämer, Oliver H, Lange, Falko, Krause, Bernd J, Klar, Ernst, Linnebacher, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250916/
https://www.ncbi.nlm.nih.gov/pubmed/30487698
http://dx.doi.org/10.3748/wjg.v24.i43.4880
_version_ 1783373007504277504
author Gock, Michael
Mullins, Christina S
Bergner, Carina
Prall, Friedrich
Ramer, Robert
Göder, Anja
Krämer, Oliver H
Lange, Falko
Krause, Bernd J
Klar, Ernst
Linnebacher, Michael
author_facet Gock, Michael
Mullins, Christina S
Bergner, Carina
Prall, Friedrich
Ramer, Robert
Göder, Anja
Krämer, Oliver H
Lange, Falko
Krause, Bernd J
Klar, Ernst
Linnebacher, Michael
author_sort Gock, Michael
collection PubMed
description AIM: To establish patient-individual tumor models of rectal cancer for analyses of novel biomarkers, individual response prediction and individual therapy regimens. METHODS: Establishment of cell lines was conducted by direct in vitro culturing and in vivo xenografting with subsequent in vitro culturing. Cell lines were in-depth characterized concerning morphological features, invasive and migratory behavior, phenotype, molecular profile including mutational analysis, protein expression, and confirmation of origin by DNA fingerprint. Assessment of chemosensitivity towards an extensive range of current chemotherapeutic drugs and of radiosensitivity was performed including analysis of a combined radio- and chemotherapeutic treatment. In addition, glucose metabolism was assessed with (18)F-fluorodeoxyglucose (FDG) and proliferation with (18)F-fluorothymidine. RESULTS: We describe the establishment of ultra-low passage rectal cancer cell lines of three patients suffering from rectal cancer. Two cell lines (HROC126, HROC284Met) were established directly from tumor specimens while HROC239 T0 M1 was established subsequent to xenografting of the tumor. Molecular analysis classified all three cell lines as CIMP-0/ non-MSI-H (sporadic standard) type. Mutational analysis revealed following mutational profiles: HROC126: APC(wt), TP53(wt), KRAS(wt), BRAF(wt), PTEN(wt); HROC239 T0 M1: APC(mut), P53(wt), KRAS(mut), BRAF(wt), PTEN(mut) and HROC284Met: APC(wt), P53(mut), KRAS(mut), BRAF(wt), PTEN(mut). All cell lines could be characterized as epithelial (EpCAM(+)) tumor cells with equivalent morphologic features and comparable growth kinetics. The cell lines displayed a heterogeneous response toward chemotherapy, radiotherapy and their combined application. HROC126 showed a highly radio-resistant phenotype and HROC284Met was more susceptible to a combined radiochemotherapy than HROC126 and HROC239 T0 M1. Analysis of (18)F-FDG uptake displayed a markedly reduced FDG uptake of all three cell lines after combined radiochemotherapy. CONCLUSION: These newly established and in-depth characterized ultra-low passage rectal cancer cell lines provide a useful instrument for analysis of biological characteristics of rectal cancer.
format Online
Article
Text
id pubmed-6250916
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-62509162018-11-28 Establishment, functional and genetic characterization of three novel patient-derived rectal cancer cell lines Gock, Michael Mullins, Christina S Bergner, Carina Prall, Friedrich Ramer, Robert Göder, Anja Krämer, Oliver H Lange, Falko Krause, Bernd J Klar, Ernst Linnebacher, Michael World J Gastroenterol Basic Study AIM: To establish patient-individual tumor models of rectal cancer for analyses of novel biomarkers, individual response prediction and individual therapy regimens. METHODS: Establishment of cell lines was conducted by direct in vitro culturing and in vivo xenografting with subsequent in vitro culturing. Cell lines were in-depth characterized concerning morphological features, invasive and migratory behavior, phenotype, molecular profile including mutational analysis, protein expression, and confirmation of origin by DNA fingerprint. Assessment of chemosensitivity towards an extensive range of current chemotherapeutic drugs and of radiosensitivity was performed including analysis of a combined radio- and chemotherapeutic treatment. In addition, glucose metabolism was assessed with (18)F-fluorodeoxyglucose (FDG) and proliferation with (18)F-fluorothymidine. RESULTS: We describe the establishment of ultra-low passage rectal cancer cell lines of three patients suffering from rectal cancer. Two cell lines (HROC126, HROC284Met) were established directly from tumor specimens while HROC239 T0 M1 was established subsequent to xenografting of the tumor. Molecular analysis classified all three cell lines as CIMP-0/ non-MSI-H (sporadic standard) type. Mutational analysis revealed following mutational profiles: HROC126: APC(wt), TP53(wt), KRAS(wt), BRAF(wt), PTEN(wt); HROC239 T0 M1: APC(mut), P53(wt), KRAS(mut), BRAF(wt), PTEN(mut) and HROC284Met: APC(wt), P53(mut), KRAS(mut), BRAF(wt), PTEN(mut). All cell lines could be characterized as epithelial (EpCAM(+)) tumor cells with equivalent morphologic features and comparable growth kinetics. The cell lines displayed a heterogeneous response toward chemotherapy, radiotherapy and their combined application. HROC126 showed a highly radio-resistant phenotype and HROC284Met was more susceptible to a combined radiochemotherapy than HROC126 and HROC239 T0 M1. Analysis of (18)F-FDG uptake displayed a markedly reduced FDG uptake of all three cell lines after combined radiochemotherapy. CONCLUSION: These newly established and in-depth characterized ultra-low passage rectal cancer cell lines provide a useful instrument for analysis of biological characteristics of rectal cancer. Baishideng Publishing Group Inc 2018-11-21 2018-11-21 /pmc/articles/PMC6250916/ /pubmed/30487698 http://dx.doi.org/10.3748/wjg.v24.i43.4880 Text en ©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Basic Study
Gock, Michael
Mullins, Christina S
Bergner, Carina
Prall, Friedrich
Ramer, Robert
Göder, Anja
Krämer, Oliver H
Lange, Falko
Krause, Bernd J
Klar, Ernst
Linnebacher, Michael
Establishment, functional and genetic characterization of three novel patient-derived rectal cancer cell lines
title Establishment, functional and genetic characterization of three novel patient-derived rectal cancer cell lines
title_full Establishment, functional and genetic characterization of three novel patient-derived rectal cancer cell lines
title_fullStr Establishment, functional and genetic characterization of three novel patient-derived rectal cancer cell lines
title_full_unstemmed Establishment, functional and genetic characterization of three novel patient-derived rectal cancer cell lines
title_short Establishment, functional and genetic characterization of three novel patient-derived rectal cancer cell lines
title_sort establishment, functional and genetic characterization of three novel patient-derived rectal cancer cell lines
topic Basic Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250916/
https://www.ncbi.nlm.nih.gov/pubmed/30487698
http://dx.doi.org/10.3748/wjg.v24.i43.4880
work_keys_str_mv AT gockmichael establishmentfunctionalandgeneticcharacterizationofthreenovelpatientderivedrectalcancercelllines
AT mullinschristinas establishmentfunctionalandgeneticcharacterizationofthreenovelpatientderivedrectalcancercelllines
AT bergnercarina establishmentfunctionalandgeneticcharacterizationofthreenovelpatientderivedrectalcancercelllines
AT prallfriedrich establishmentfunctionalandgeneticcharacterizationofthreenovelpatientderivedrectalcancercelllines
AT ramerrobert establishmentfunctionalandgeneticcharacterizationofthreenovelpatientderivedrectalcancercelllines
AT goderanja establishmentfunctionalandgeneticcharacterizationofthreenovelpatientderivedrectalcancercelllines
AT krameroliverh establishmentfunctionalandgeneticcharacterizationofthreenovelpatientderivedrectalcancercelllines
AT langefalko establishmentfunctionalandgeneticcharacterizationofthreenovelpatientderivedrectalcancercelllines
AT krauseberndj establishmentfunctionalandgeneticcharacterizationofthreenovelpatientderivedrectalcancercelllines
AT klarernst establishmentfunctionalandgeneticcharacterizationofthreenovelpatientderivedrectalcancercelllines
AT linnebachermichael establishmentfunctionalandgeneticcharacterizationofthreenovelpatientderivedrectalcancercelllines